TSO3 INC.

TSO3 Inc. Announces Completion of Arrangement

Retrieved on: 
Tuesday, October 1, 2019
Economy of Canada, System for Electronic Document Analysis and Retrieval, Sterilization, Letter of transmittal, Articles

A copy of the Letter of Transmittal may also be obtained by contacting the Depositary and is available on SEDAR at www.sedar.com under the Company's profile.

Key Points: 
  • A copy of the Letter of Transmittal may also be obtained by contacting the Depositary and is available on SEDAR at www.sedar.com under the Company's profile.
  • As a result of the completion of the Arrangement, it is expected that the Shares will soon be delisted from the Toronto Stock Exchange.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
  • Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties.

TSO3 Inc. Confirms Purchase Price of CAD $0.43 per Share

Retrieved on: 
Thursday, September 19, 2019
Biocides, Electron beam, Hygiene, Microbiology, Sterilization, Proxy

As the amount of transaction costs does not exceed the threshold previously agreed upon by the parties, no adjustment is made to the consideration and each Shareholder will receive CAD $0.43 in cash for each share held upon closing of the Arrangement.

Key Points: 
  • As the amount of transaction costs does not exceed the threshold previously agreed upon by the parties, no adjustment is made to the consideration and each Shareholder will receive CAD $0.43 in cash for each share held upon closing of the Arrangement.
  • The Company has retained Shorecrest Group Inc. to act as its proxy solicitation agent and to answer information requests from shareholders.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
  • For more information about TSO3, visit the Company's website at www.tso3.com .

TSO3 Announces the Vote Results from its Annual Meeting of the Shareholders

Retrieved on: 
Wednesday, May 8, 2019
Economy of Canada, System for Electronic Document Analysis and Retrieval, Sterilization, Medical device, Light-emitting diode, Articles, Electromagnetism, Light

Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2019, will be filed on SEDAR ( www.sedar.com ) under the name TSO3.

Key Points: 
  • Final voting results on all matters voted at the Annual Meeting of Shareholders held on May 7, 2019, will be filed on SEDAR ( www.sedar.com ) under the name TSO3.
  • Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
  • For more information about TSO3, visit the Company's website at www.tso3.com .

TSO3 Announces the Dates of its First Quarter 2019 Earnings Conference Call and Annual General Meeting of Shareholders

Retrieved on: 
Tuesday, April 30, 2019
Biocides, Electron beam, Hygiene, Microbiology, Sterilization, Medical device, Articles, Maintenance, Assurance services, Academic disciplines, Public health

Subsequent to the conclusion of the Annual Meeting of Shareholders, there will be a presentation by Mr.Rumble regarding the Company's business.

Key Points: 
  • Subsequent to the conclusion of the Annual Meeting of Shareholders, there will be a presentation by Mr.Rumble regarding the Company's business.
  • Founded in 1998, TSO3's activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
  • Although TSO3 believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.

TSO3 Announces Changes to the Board of Directors

Retrieved on: 
Tuesday, April 2, 2019
Articles, Rosenstock, Sterilization, Board of directors, Business, Public health

"We are pleased to welcome Sara to our board of directors," stated Dr. Linda Rosenstock, Chairperson of the board of TSO3.

Key Points: 
  • "We are pleased to welcome Sara to our board of directors," stated Dr. Linda Rosenstock, Chairperson of the board of TSO3.
  • The Company also announced that Douglas Dieter has tendered his resignation as a member of the board of directors.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
  • For more information about TSO3, visit the Company's website at www.tso3.com .

TSO3 Announces Date of Fourth Quarter and Full Year 2018 Earnings Conference Call

Retrieved on: 
Thursday, March 21, 2019
Biocides, Electron beam, Hygiene, Microbiology, Sterilization, Natural sciences

Please call the conference telephone number 5-10 minutes prior to the start time.

Key Points: 
  • Please call the conference telephone number 5-10 minutes prior to the start time.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
  • For more information about TSO3, visit the Company's website at www.tso3.com .
  • Although TSO3 believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.

TSO3 Expands Duodenoscope Sterilization Testing

Retrieved on: 
Thursday, March 14, 2019
Chemical substances, Chemistry, Physical sciences, Disinfectants, Antiseptics, Hydrogen peroxide, Oxidizing agents, Sterilization, Vaporized hydrogen peroxide, Ozone, Endoscopy, Autoclave

TSO3 is dedicated to helping our customers continually innovate and improve patient care with best-in-class technology applications directed at infection prevention."

Key Points: 
  • TSO3 is dedicated to helping our customers continually innovate and improve patient care with best-in-class technology applications directed at infection prevention."
  • Although the Fujifilm duodenoscope dimensions fall within TSO3's US Food and Drug Administration (FDA) cleared label claim for sterilization of long, flexible gastro-intestinal endoscopes (see claims at tso3.com ), the additional data TSO3 will generate as a result of the testing is intended to further support customer needs for device documentation.
  • The STERIZONE VP4 Sterilizer is a low-temperature sterilization system that utilizes the dual sterilants of vaporized hydrogen peroxide (H2O2) and ozone (O3) to achieve terminal sterilization of heat and moisture-sensitive medical devices.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

American Journal of Infection Control publishes TSO3 study on terminal sterilization of duodenoscopes

Retrieved on: 
Thursday, November 15, 2018
Chemistry, Disinfectants, Oxidizing agents, Hygiene, Biocides, Electron beam, Sterilization, Hydrogen peroxide, Ozone, Infection control, Autoclave

("TSO3" or the "Company") (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announces today that the results of the Company's clinical in-use and simulated use testing of the terminal sterilization of duodenoscopes have been published in the American Journal of Infection Control.

Key Points: 
  • ("TSO3" or the "Company") (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, announces today that the results of the Company's clinical in-use and simulated use testing of the terminal sterilization of duodenoscopes have been published in the American Journal of Infection Control.
  • The paper is titled "Elevating the standard of endoscope processing: terminal sterilization of duodenoscopes using a hydrogen peroxide-ozone sterilizer."
  • The STERIZONE VP4 Sterilizer is a low-temperature sterilization system that utilizes the dual sterilants of vaporized hydrogen peroxide (H2O2) and ozone (O3) to achieve terminal sterilization of heat and moisture-sensitive medical devices.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.

TSO3 Named Winner of South Carolina Innovation Award

Retrieved on: 
Monday, October 29, 2018
Biocides, Electron beam, Hygiene, Microbiology, Sterilization, Autoclave, Biology

MYRTLE BEACH, SC and QUEBEC CITY, Oct. 29, 2018 /PRNewswire/ -TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, was named the winner of the South Carolina Chamber of Commerce's SC Branded Product Innovation Award.

Key Points: 
  • MYRTLE BEACH, SC and QUEBEC CITY, Oct. 29, 2018 /PRNewswire/ -TSO3 Inc. (TSX: TOS) ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, was named the winner of the South Carolina Chamber of Commerce's SC Branded Product Innovation Award.
  • This award follows the FDA clearance of the Company's paradigm-shifting STERIZONE VP4 Sterilizer to terminally sterilize multi-channeled flexible endoscopes in healthcare settings.
  • "We are honored to be the winner of the innovation award by the South Carolina Chamber of Commerce," said R.M.
  • The SC Branded Product Innovation Award recognizes the company whose newest development is bringing attention and growth to South Carolina.

TSO3 to Report Third Quarter 2018 Results on Wednesday, November 7, 2018

Retrieved on: 
Thursday, October 25, 2018
Hygiene, Chemistry, Biocides, Electron beam, Microbiology, Sterilization, Myrtle Beach, South Carolina, Polyvinyl chloride, Matter, Biology

QUEBEC CITY and MYRTLE BEACH, SC, Oct. 25, 2018 /PRNewswire/ -TSO3 Inc. (TSX: TOS), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, November 7, 2018 to discuss its financial results for the third quarter ended September 30, 2018.

Key Points: 
  • QUEBEC CITY and MYRTLE BEACH, SC, Oct. 25, 2018 /PRNewswire/ -TSO3 Inc. (TSX: TOS), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, will hold a conference call on Wednesday, November 7, 2018 to discuss its financial results for the third quarter ended September 30, 2018.
  • Financial results will be issued in a press release prior to the call.
  • TSO3 also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes.
  • For more information about TSO3, visit the Company's website at www.tso3.com .